IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 221 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $337 | -86.1% | 42 | -74.4% | 0.00% | – |
Q1 2024 | $2,430 | +145.0% | 164 | +34.4% | 0.00% | – |
Q4 2023 | $992 | – | 122 | 0.0% | 0.00% | – |
Q3 2023 | $0 | -100.0% | 122 | -43.8% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 217 | +31.5% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 165 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -100.0% | 165 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | – | 165 | +1733.3% | 0.00% | – |
Q1 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 9 | -100.0% | 0.00% | -100.0% |
Q2 2020 | $1,204,000 | +9.3% | 43,880 | +19.2% | 0.03% | 0.0% |
Q1 2020 | $1,102,000 | – | 36,813 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
CM Management, LLC | 200,000 | $910,000 | 0.97% |
Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |